Skip to content

Clinical trials

Phase 1 Carcinoma, Non-Small-Cell Lung trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1 Country / region: Switzerland Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20132
20141
20161
20171
20202
20211
20223
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated5
Active, not recruiting3
Recruiting3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
European Organisation for Research and Treatment of Cancer - EORTC2
Seagen, a wholly owned subsidiary of Pfizer2
Amgen1
Bayer1
Centre Hospitalier Universitaire Vaudois1
CureVac1
Dr Jean Yannis PERENTES1
EMD Serono1
Exelixis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung18
Colorectal Neoplasms6
Ovarian Neoplasms5
Breast Neoplasms4
Melanoma4
Stomach Neoplasms3
Esophageal Neoplasms2
Lung Neoplasms2
Pancreatic Neoplasms2
Prostatic Neoplasms2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.